Don't have Telegram yet? Try it now!
https://magazine.pharmamkt.net/2018/07/02/chmp-issues-positive-opinion-to-expand-jardiance-synjardy-and-glyxambi-labels-to-include-positive-effects-on-cardiovascular-and-renal-outcomes/
CHMP issues positive opinion to expand Jardiance®, Synjardy® and Glyxambi® labels to include positive effects on cardiovascular and renal outcomes